Free Trial

Rodman & Renshaw Analyst Recommendations & Stock Picks

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Rodman & Renshaw. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Rodman & Renshaw.

MarketBeat Brokerage Ranking:
Average 12-Month ROI of Buy Recommendations: Subscribe to Unlock


MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyCurrent PriceReport DateAnalystActionRatingPrice TargetDetailsActions
Telomir Pharmaceuticals stock logo
TELO
Telomir Pharmaceuticals
$1.76
-5.9%
2/21/2025-Initiated CoverageBuy$15.00View details for Rodman & Renshaw rating of Telomir Pharmaceuticals (NASDAQ:TELO) on 2/21/2025
PolyPid stock logo
PYPD
PolyPid
$3.41
+1.5%
1/28/2025-Initiated CoverageBuy$13.00View details for Rodman & Renshaw rating of PolyPid (NASDAQ:PYPD) on 1/28/2025
INmune Bio stock logo
INMB
INmune Bio
$2.56
-6.2%
1/28/2025-Initiated CoverageBuy$23.00View details for Rodman & Renshaw rating of INmune Bio (NASDAQ:INMB) on 1/28/2025
Indivior stock logo
INDV
Indivior
$21.05
+4.2%
1/28/2025-Initiated CoverageBuy$16.00View details for Rodman & Renshaw rating of Indivior (NASDAQ:INDV) on 1/28/2025
Cardiol Therapeutics stock logo
CRDL
Cardiol Therapeutics
$1.38
-7.4%
1/28/2025-Initiated CoverageBuy$7.00View details for Rodman & Renshaw rating of Cardiol Therapeutics (NASDAQ:CRDL) on 1/28/2025
Atara Biotherapeutics stock logo
ATRA
Atara Biotherapeutics
$11.55
+0.3%
12/20/2024-Initiated CoverageBuy$25.00View details for Rodman & Renshaw rating of Atara Biotherapeutics (NASDAQ:ATRA) on 12/20/2024
TuHURA Biosciences stock logo
HURA
TuHURA Biosciences
$2.40
-3.2%
12/19/2024-Initiated CoverageBuy$11.00View details for Rodman & Renshaw rating of TuHURA Biosciences (NASDAQ:HURA) on 12/19/2024
FibroBiologics stock logo
FBLG
FibroBiologics
$0.65
+1.8%
12/12/2024-Initiated CoverageBuy$12.00View details for Rodman & Renshaw rating of FibroBiologics (NASDAQ:FBLG) on 12/12/2024
Rockwell Medical stock logo
RMTI
Rockwell Medical
$0.96
+2.8%
11/14/2024-Initiated CoverageBuy$5.00View details for Rodman & Renshaw rating of Rockwell Medical (NASDAQ:RMTI) on 11/14/2024
Omeros stock logo
OMER
Omeros
$3.61
-6.7%
11/14/2024-Initiated CoverageBuy$9.00View details for Rodman & Renshaw rating of Omeros (NASDAQ:OMER) on 11/14/2024
Eupraxia Pharmaceuticals stock logo
EPRX
Eupraxia Pharmaceuticals
$5.30
-1.8%
11/14/2024-Initiated CoverageBuy$9.00View details for Rodman & Renshaw rating of Eupraxia Pharmaceuticals (NASDAQ:EPRX) on 11/14/2024
Achieve Life Sciences stock logo
ACHV
Achieve Life Sciences
$2.55
-2.3%
11/14/2024-Initiated CoverageBuy$12.00View details for Rodman & Renshaw rating of Achieve Life Sciences (NASDAQ:ACHV) on 11/14/2024
Bicara Therapeutics stock logo
BCAX
Bicara Therapeutics
$10.53
-5.2%
11/5/2024-Initiated CoverageBuy$48.00View details for Rodman & Renshaw rating of Bicara Therapeutics (NASDAQ:BCAX) on 11/5/2024
Quince Therapeutics stock logo
QNCX
Quince Therapeutics
$1.68
-0.6%
10/29/2024-Initiated CoverageBuy$11.00View details for Rodman & Renshaw rating of Quince Therapeutics (NASDAQ:QNCX) on 10/29/2024
Alto Neuroscience stock logo
ANRO
Alto Neuroscience
$3.06
-0.3%
10/23/2024-DowngradeBuy -> NeutralView details for Rodman & Renshaw rating of Alto Neuroscience (NYSE:ANRO) on 10/23/2024
Monopar Therapeutics stock logo
MNPR
Monopar Therapeutics
$40.69
-1.2%
10/11/2024-Initiated CoverageBuy$50.00View details for Rodman & Renshaw rating of Monopar Therapeutics (NASDAQ:MNPR) on 10/11/2024
Nkarta stock logo
NKTX
Nkarta
$2.12
-2.3%
10/9/2024-Initiated CoverageBuy$14.00View details for Rodman & Renshaw rating of Nkarta (NASDAQ:NKTX) on 10/9/2024
Kyverna Therapeutics stock logo
KYTX
Kyverna Therapeutics
$3.44
-3.6%
10/9/2024-Initiated CoverageBuy$16.00View details for Rodman & Renshaw rating of Kyverna Therapeutics (NASDAQ:KYTX) on 10/9/2024
MIRA Pharmaceuticals stock logo
MIRA
MIRA Pharmaceuticals
$1.54
-6.7%
9/30/2024-Initiated CoverageBuy$17.00View details for Rodman & Renshaw rating of MIRA Pharmaceuticals (NASDAQ:MIRA) on 9/30/2024
Biomea Fusion stock logo
BMEA
Biomea Fusion
$1.57
-5.4%
9/26/2024-UpgradeNeutral -> Buy$18.00View details for Rodman & Renshaw rating of Biomea Fusion (NASDAQ:BMEA) on 9/26/2024
Emergent Biosolutions stock logo
EBS
Emergent Biosolutions
$5.63
-4.3%
9/13/2024-Reiterated RatingBuy -> Buy$16.00 -> $16.00View details for Rodman & Renshaw rating of Emergent Biosolutions (NYSE:EBS) on 9/13/2024
Athira Pharma stock logo
ATHA
Athira Pharma
$0.37
-2.6%
9/4/2024-DowngradeBuy -> NeutralView details for Rodman & Renshaw rating of Athira Pharma (NASDAQ:ATHA) on 9/4/2024
Passage Bio stock logo
PASG
Passage Bio
$5.74
-10.6%
9/3/2024-Initiated CoverageBuy$140.00View details for Rodman & Renshaw rating of Passage Bio (NASDAQ:PASG) on 9/3/2024
CorMedix stock logo
CRMD
CorMedix
$11.64
-0.3%
8/26/2024-Initiated CoverageBuy$13.00View details for Rodman & Renshaw rating of CorMedix (NASDAQ:CRMD) on 8/26/2024
Milestone Pharmaceuticals stock logo
MIST
Milestone Pharmaceuticals
$1.43
-1.4%
8/22/2024-Initiated CoverageBuy$9.00View details for Rodman & Renshaw rating of Milestone Pharmaceuticals (NASDAQ:MIST) on 8/22/2024
Journey Medical stock logo
DERM
Journey Medical
$6.99
-4.9%
8/22/2024-Initiated CoverageBuy$9.00View details for Rodman & Renshaw rating of Journey Medical (NASDAQ:DERM) on 8/22/2024
Emergent Biosolutions stock logo
EBS
Emergent Biosolutions
$5.63
-4.3%
8/22/2024-Initiated CoverageBuy$16.00View details for Rodman & Renshaw rating of Emergent Biosolutions (NYSE:EBS) on 8/22/2024
Athira Pharma stock logo
ATHA
Athira Pharma
$0.37
-2.6%
8/19/2024-Initiated CoverageBuy$22.00View details for Rodman & Renshaw rating of Athira Pharma (NASDAQ:ATHA) on 8/19/2024
Cassava Sciences stock logo
SAVA
Cassava Sciences
$2.12
+1.0%
8/8/2024-Reiterated RatingBuy -> Buy$107.00 -> $107.00View details for Rodman & Renshaw rating of Cassava Sciences (NASDAQ:SAVA) on 8/8/2024
Century Therapeutics stock logo
IPSC
Century Therapeutics
$0.53
-2.9%
8/8/2024-Initiated CoverageBuy$6.00View details for Rodman & Renshaw rating of Century Therapeutics (NASDAQ:IPSC) on 8/8/2024
CRISPR Therapeutics stock logo
CRSP
CRISPR Therapeutics
$56.09
-0.3%
8/2/2024-Initiated CoverageBuy$90.00View details for Rodman & Renshaw rating of CRISPR Therapeutics (NASDAQ:CRSP) on 8/2/2024
Annovis Bio stock logo
ANVS
Annovis Bio
$2.51
-8.1%
7/2/2024-Reiterated RatingBuy -> Buy$67.00 -> $67.00View details for Rodman & Renshaw rating of Annovis Bio (NYSE:ANVS) on 7/2/2024
Cognition Therapeutics stock logo
CGTX
Cognition Therapeutics
$0.67
+13.9%
7/2/2024-Reiterated RatingBuy -> Buy$14.00 -> $14.00View details for Rodman & Renshaw rating of Cognition Therapeutics (NASDAQ:CGTX) on 7/2/2024
Nektar Therapeutics stock logo
NKTR
Nektar Therapeutics
$22.96
+5.9%
6/28/2024-Initiated CoverageBuy$30.00View details for Rodman & Renshaw rating of Nektar Therapeutics (NASDAQ:NKTR) on 6/28/2024
Leap Therapeutics stock logo
LPTX
Leap Therapeutics
$0.31
-1.3%
6/28/2024-Initiated CoverageBuy$8.00View details for Rodman & Renshaw rating of Leap Therapeutics (NASDAQ:LPTX) on 6/28/2024
Mural Oncology stock logo
MURA
Mural Oncology
$2.32
+3.1%
6/28/2024-Initiated CoverageBuy$15.00View details for Rodman & Renshaw rating of Mural Oncology (NASDAQ:MURA) on 6/28/2024
Sana Biotechnology stock logo
SANA
Sana Biotechnology
$3.91
-3.7%
6/26/2024-Initiated CoverageBuy$16.00View details for Rodman & Renshaw rating of Sana Biotechnology (NASDAQ:SANA) on 6/26/2024
Alto Neuroscience stock logo
ANRO
Alto Neuroscience
$3.06
-0.3%
6/21/2024-Initiated CoverageBuy$43.00View details for Rodman & Renshaw rating of Alto Neuroscience (NYSE:ANRO) on 6/21/2024
Coya Therapeutics stock logo
COYA
Coya Therapeutics
$6.09
+2.4%
6/13/2024-Initiated CoverageBuy$18.00View details for Rodman & Renshaw rating of Coya Therapeutics (NASDAQ:COYA) on 6/13/2024
Trevi Therapeutics stock logo
TRVI
Trevi Therapeutics
$7.33
-1.1%
6/13/2024-Initiated CoverageBuy$7.00View details for Rodman & Renshaw rating of Trevi Therapeutics (NASDAQ:TRVI) on 6/13/2024
BREAKING: The House just passed 3 pro-crypto bills! (Ad)

THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here.

Discover the under-the-radar project I believe will skyrocket as a result.
Scilex stock logo
SCLX
Scilex
$13.41
-0.1%
6/13/2024-Initiated CoverageBuy$455.00View details for Rodman & Renshaw rating of Scilex (NASDAQ:SCLX) on 6/13/2024
Rani Therapeutics stock logo
RANI
Rani Therapeutics
$0.53
-1.4%
6/13/2024-Initiated CoverageBuy$10.00View details for Rodman & Renshaw rating of Rani Therapeutics (NASDAQ:RANI) on 6/13/2024
MannKind stock logo
MNKD
MannKind
$3.75
-0.8%
6/13/2024-Initiated CoverageBuy$8.00View details for Rodman & Renshaw rating of MannKind (NASDAQ:MNKD) on 6/13/2024
Heron Therapeutics stock logo
HRTX
Heron Therapeutics
$1.69
-2.3%
6/13/2024-Initiated CoverageBuy$7.00View details for Rodman & Renshaw rating of Heron Therapeutics (NASDAQ:HRTX) on 6/13/2024
Avadel Pharmaceuticals stock logo
AVDL
Avadel Pharmaceuticals
$11.08
+5.4%
6/12/2024-Initiated CoverageBuy$27.00View details for Rodman & Renshaw rating of Avadel Pharmaceuticals (NASDAQ:AVDL) on 6/12/2024
Annovis Bio stock logo
ANVS
Annovis Bio
$2.51
-8.1%
6/4/2024-Initiated CoverageBuy$67.00View details for Rodman & Renshaw rating of Annovis Bio (NYSE:ANVS) on 6/4/2024
Bausch Health Cos stock logo
BHC
Bausch Health Cos
$5.71
-3.1%
8/10/2017-Reiterated RatingNeutral$17.00View details for Rodman & Renshaw rating of Bausch Health Cos (NYSE:BHC) on 8/10/2017
CorMedix stock logo
CRMD
CorMedix
$11.64
-0.3%
8/10/2017-Lower Price TargetBuy -> Buy$25.00 -> $15.00View details for Rodman & Renshaw rating of CorMedix (NASDAQ:CRMD) on 8/10/2017
Gevo stock logo
GEVO
Gevo
$1.22
-6.2%
8/9/2017-Reiterated RatingBuy$240.00View details for Rodman & Renshaw rating of Gevo (NASDAQ:GEVO) on 8/9/2017
POET Technologies stock logo
POETF
POET Technologies
$5.50
-4.3%
8/7/2017-Initiated CoverageBuyView details for Rodman & Renshaw rating of POET Technologies (OTCMKTS:POETF) on 8/7/2017
Veru stock logo
VERU
Veru
$0.49
+1.8%
7/26/2017-Initiated CoverageBuy -> Buy$5.00View details for Rodman & Renshaw rating of Veru (NASDAQ:VERU) on 7/26/2017
Plug Power stock logo
PLUG
Plug Power
$1.40
-6.7%
7/24/2017-Reiterated RatingBuy$4.00View details for Rodman & Renshaw rating of Plug Power (NASDAQ:PLUG) on 7/24/2017
Capricor Therapeutics stock logo
CAPR
Capricor Therapeutics
$7.90
-3.4%
7/22/2017-Reiterated RatingBuy$2.15View details for Rodman & Renshaw rating of Capricor Therapeutics (NASDAQ:CAPR) on 7/22/2017
BeyondSpring stock logo
BYSI
BeyondSpring
$2.07
+1.0%
7/14/2017-Boost Price TargetBuy -> Buy$43.00 -> $50.00View details for Rodman & Renshaw rating of BeyondSpring (NASDAQ:BYSI) on 7/14/2017
Fortress Biotech stock logo
FBIO
Fortress Biotech
$1.81
-2.2%
7/11/2017-Initiated CoverageBuy -> Buy$165.00View details for Rodman & Renshaw rating of Fortress Biotech (NASDAQ:FBIO) on 7/11/2017
eMagin stock logo
EMAN
eMagin
$2.07
6/23/2017-Reiterated RatingBuy$4.00View details for Rodman & Renshaw rating of eMagin (NYSEAMERICAN:EMAN) on 6/23/2017
Americas Silver stock logo
USA
Americas Silver
C$1.27
+0.8%
6/15/2017-Initiated CoverageBuyC$4.00View details for Rodman & Renshaw rating of Americas Silver (TSE:USA) on 6/15/2017
Americas Gold and Silver stock logo
USAS
Americas Gold and Silver
$0.92
+3.6%
6/15/2017-Initiated CoverageBuy -> Buy$4.00 -> $4.00View details for Rodman & Renshaw rating of Americas Gold and Silver (NYSEAMERICAN:USAS) on 6/15/2017
Eyepoint Pharmaceuticals stock logo
EYPT
Eyepoint Pharmaceuticals
$9.71
-1.1%
5/30/2017-Initiated CoverageBuy$800.00View details for Rodman & Renshaw rating of Eyepoint Pharmaceuticals (NASDAQ:EYPT) on 5/30/2017
Protalix BioTherapeutics stock logo
PLX
Protalix BioTherapeutics
$1.45
-0.7%
5/23/2017-Reiterated RatingBuy$50.00View details for Rodman & Renshaw rating of Protalix BioTherapeutics (NYSE:PLX) on 5/23/2017
ACADIA Pharmaceuticals stock logo
ACAD
ACADIA Pharmaceuticals
$23.53
-1.3%
5/22/2017-Reiterated RatingBuy$60.00View details for Rodman & Renshaw rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 5/22/2017
Bausch Health Cos stock logo
BHC
Bausch Health Cos
$5.71
-3.1%
5/19/2017-Reiterated RatingNeutral$17.00View details for Rodman & Renshaw rating of Bausch Health Cos (NYSE:BHC) on 5/19/2017
Magic Software Enterprises stock logo
MGIC
Magic Software Enterprises
$20.60
-0.5%
5/17/2017-Reiterated RatingBuy -> Buy$9.00 -> $10.00View details for Rodman & Renshaw rating of Magic Software Enterprises (NASDAQ:MGIC) on 5/17/2017
Iovance Biotherapeutics stock logo
IOVA
Iovance Biotherapeutics
$2.68
+4.3%
5/10/2017-Initiated CoverageBuy -> Buy$13.00View details for Rodman & Renshaw rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 5/10/2017
CorMedix stock logo
CRMD
CorMedix
$11.64
-0.3%
5/5/2017-Lower Price TargetBuy$30.00 -> $25.00View details for Rodman & Renshaw rating of CorMedix (NASDAQ:CRMD) on 5/5/2017
American Superconductor stock logo
AMSC
American Superconductor
$53.75
-5.5%
4/28/2017-Reiterated RatingBuy -> Buy$10.00 -> $7.50View details for Rodman & Renshaw rating of American Superconductor (NASDAQ:AMSC) on 4/28/2017
Barrick Mining stock logo
B
Barrick Mining
$21.36
+1.1%
4/24/2017-Boost Price TargetBuy$4.25 -> $4.50View details for Rodman & Renshaw rating of Barrick Mining (NYSE:B) on 4/24/2017
Protalix BioTherapeutics stock logo
PLX
Protalix BioTherapeutics
$1.45
-0.7%
4/17/2017-Boost Price TargetBuy$40.00 -> $50.00View details for Rodman & Renshaw rating of Protalix BioTherapeutics (NYSE:PLX) on 4/17/2017
Protalix BioTherapeutics stock logo
PLX
Protalix BioTherapeutics
$1.45
-0.7%
4/17/2017-Reiterated RatingBuy -> Buy$40.00 -> $50.00View details for Rodman & Renshaw rating of Protalix BioTherapeutics (NYSE:PLX) on 4/17/2017
Western Copper and Gold stock logo
WRN
Western Copper and Gold
C$1.66
-1.8%
4/10/2017-Reiterated RatingBuyC$2.00View details for Rodman & Renshaw rating of Western Copper and Gold (TSE:WRN) on 4/10/2017
Western Copper and Gold stock logo
WRN
Western Copper and Gold
$1.20
-2.4%
4/7/2017-Reiterated RatingBuy$2.00View details for Rodman & Renshaw rating of Western Copper and Gold (NYSEAMERICAN:WRN) on 4/7/2017
Plug Power stock logo
PLUG
Plug Power
$1.40
-6.7%
4/6/2017-Boost Price TargetBuy -> Buy$3.00 -> $4.00View details for Rodman & Renshaw rating of Plug Power (NASDAQ:PLUG) on 4/6/2017
BeyondSpring stock logo
BYSI
BeyondSpring
$2.07
+1.0%
4/4/2017-Initiated CoverageBuy -> Buy$43.00View details for Rodman & Renshaw rating of BeyondSpring (NASDAQ:BYSI) on 4/4/2017
Cytokinetics stock logo
CYTK
Cytokinetics
$36.69
-2.5%
3/23/2017-Reiterated RatingBuy$25.00View details for Rodman & Renshaw rating of Cytokinetics (NASDAQ:CYTK) on 3/23/2017
Harrow stock logo
HROW
Harrow
$31.23
-1.7%
3/22/2017-Reiterated RatingBuy$5.00View details for Rodman & Renshaw rating of Harrow (NASDAQ:HROW) on 3/22/2017
MAG Silver stock logo
MAG
MAG Silver
$20.33
-0.4%
3/9/2017-Reiterated RatingBuy -> Buy$20.00 -> $20.50View details for Rodman & Renshaw rating of MAG Silver (NYSEAMERICAN:MAG) on 3/9/2017
Cytokinetics stock logo
CYTK
Cytokinetics
$36.69
-2.5%
3/8/2017-Initiated CoverageBuy -> Buy$25.00View details for Rodman & Renshaw rating of Cytokinetics (NASDAQ:CYTK) on 3/8/2017
Bausch Health Cos stock logo
BHC
Bausch Health Cos
$5.71
-3.1%
3/6/2017-Lower Price TargetNeutral$23.00 -> $17.00View details for Rodman & Renshaw rating of Bausch Health Cos (NYSE:BHC) on 3/6/2017
Magic Software Enterprises stock logo
MGIC
Magic Software Enterprises
$20.60
-0.5%
3/6/2017-Reiterated RatingBuy -> Buy$8.00 -> $9.00View details for Rodman & Renshaw rating of Magic Software Enterprises (NASDAQ:MGIC) on 3/6/2017
Quest Resource stock logo
QRHC
Quest Resource
$2.02
+0.5%
3/6/2017-Initiated CoverageBuy -> Buy$5.00View details for Rodman & Renshaw rating of Quest Resource (NASDAQ:QRHC) on 3/6/2017
Bausch Health Cos stock logo
BHC
Bausch Health Cos
$5.71
-3.1%
2/27/2017-Reiterated RatingNeutral$23.00 -> $17.00View details for Rodman & Renshaw rating of Bausch Health Cos (NYSE:BHC) on 2/27/2017
Capricor Therapeutics stock logo
CAPR
Capricor Therapeutics
$7.90
-3.4%
2/13/2017-Initiated CoverageBuy$14.00View details for Rodman & Renshaw rating of Capricor Therapeutics (NASDAQ:CAPR) on 2/13/2017
BioLineRx stock logo
BLRX
BioLineRx
$3.87
-2.8%
2/13/2017-Initiated CoverageBuy$120.00View details for Rodman & Renshaw rating of BioLineRx (NASDAQ:BLRX) on 2/13/2017
Abeona Therapeutics stock logo
ABEO
Abeona Therapeutics
$6.49
+1.9%
2/7/2017ram selvarajuReiterated RatingBuy$425.00 -> $500.00View details for Rodman & Renshaw rating of Abeona Therapeutics (NASDAQ:ABEO) on 2/7/2017
Bausch Health Cos stock logo
BHC
Bausch Health Cos
$5.71
-3.1%
1/31/2017-DowngradeBuy -> NeutralView details for Rodman & Renshaw rating of Bausch Health Cos (NYSE:BHC) on 1/31/2017
Avino Silver & Gold Mines stock logo
ASM
Avino Silver & Gold Mines
$3.23
+1.3%
1/24/2017-Boost Price TargetBuy$3.50 -> $4.00View details for Rodman & Renshaw rating of Avino Silver & Gold Mines (NYSE:ASM) on 1/24/2017
Niagen Bioscience stock logo
NAGE
Niagen Bioscience
$9.04
-3.3%
1/3/2017-Initiated CoverageBuy$6.00View details for Rodman & Renshaw rating of Niagen Bioscience (NASDAQ:NAGE) on 1/3/2017
Plug Power stock logo
PLUG
Plug Power
$1.40
-6.7%
12/6/2016-Initiated CoverageBuy$3.00View details for Rodman & Renshaw rating of Plug Power (NASDAQ:PLUG) on 12/6/2016
Barrick Mining stock logo
B
Barrick Mining
$21.36
+1.1%
11/28/2016-Boost Price TargetBuy$4.00 -> $4.25View details for Rodman & Renshaw rating of Barrick Mining (NYSE:B) on 11/28/2016
Harrow stock logo
HROW
Harrow
$31.23
-1.7%
11/28/2016-Initiated CoverageBuy$5.00View details for Rodman & Renshaw rating of Harrow (NASDAQ:HROW) on 11/28/2016
BREAKING: The House just passed 3 pro-crypto bills! (Ad)

THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here.

Discover the under-the-radar project I believe will skyrocket as a result.
Bausch Health Cos stock logo
BHC
Bausch Health Cos
$5.71
-3.1%
11/10/2016Ram SelvarajuDowngradeBuy -> Neutral$81.00 -> $23.00View details for Rodman & Renshaw rating of Bausch Health Cos (NYSE:BHC) on 11/10/2016
GoGold Resources stock logo
GGD
GoGold Resources
C$2.04
+1.0%
10/7/2016-Lower Price TargetBuyC$3.50 -> C$3.00View details for Rodman & Renshaw rating of GoGold Resources (TSE:GGD) on 10/7/2016
CytoDyn stock logo
CYDY
CytoDyn
$0.29
-1.1%
10/6/2016-Initiated CoverageBuy$1.60View details for Rodman & Renshaw rating of CytoDyn (OTCMKTS:CYDY) on 10/6/2016
Tecogen stock logo
TGEN
Tecogen
$9.18
-5.2%
10/4/2016-Initiated CoverageBuy$6.00View details for Rodman & Renshaw rating of Tecogen (OTCMKTS:TGEN) on 10/4/2016
DURECT stock logo
DRRX
DURECT
$1.84
-1.9%
9/27/2016Ram SelvarajuReiterated RatingBuy$40.00 -> $35.00View details for Rodman & Renshaw rating of DURECT (NASDAQ:DRRX) on 9/27/2016
Aytu BioPharma stock logo
AYTU
Aytu BioPharma
$2.40
-1.6%
9/26/2016-Initiated CoverageBuy$9.00View details for Rodman & Renshaw rating of Aytu BioPharma (NASDAQ:AYTU) on 9/26/2016
Clean Energy Fuels stock logo
CLNE
Clean Energy Fuels
$1.97
-3.0%
9/23/2016-Reiterated RatingBuy$5.00 -> $6.30View details for Rodman & Renshaw rating of Clean Energy Fuels (NASDAQ:CLNE) on 9/23/2016
Energy Fuels stock logo
UUUU
Energy Fuels
$8.85
-2.6%
9/22/2016-Boost Price TargetBuy$5.00 -> $6.30View details for Rodman & Renshaw rating of Energy Fuels (NYSEAMERICAN:UUUU) on 9/22/2016
Energy Fuels stock logo
UUUU
Energy Fuels
$8.85
-2.6%
9/22/2016-Lower Price TargetBuy$6.30 -> $5.00View details for Rodman & Renshaw rating of Energy Fuels (NYSEAMERICAN:UUUU) on 9/22/2016
VolitionRX stock logo
VNRX
VolitionRX
$0.64
-0.2%
9/7/2016-Lower Price TargetBuy$12.00 -> $10.00View details for Rodman & Renshaw rating of VolitionRX (NYSEAMERICAN:VNRX) on 9/7/2016
VolitionRX stock logo
VNRX
VolitionRX
$0.64
-0.2%
9/7/2016Ram SelvarajuReiterated RatingBuy$12.00 -> $10.00View details for Rodman & Renshaw rating of VolitionRX (NYSEAMERICAN:VNRX) on 9/7/2016
Midwest Energy Emissions stock logo
MEEC
Midwest Energy Emissions
$0.61
-0.8%
9/7/2016-Initiated CoverageBuy$2.50View details for Rodman & Renshaw rating of Midwest Energy Emissions (OTCMKTS:MEEC) on 9/7/2016
Hecla Mining stock logo
HL
Hecla Mining
$5.69
-0.9%
9/6/2016-Initiated CoverageBuy$9.00View details for Rodman & Renshaw rating of Hecla Mining (NYSE:HL) on 9/6/2016
Ring Energy stock logo
REI
Ring Energy
$0.73
-4.6%
8/29/2016-Initiated CoverageBuy$15.00View details for Rodman & Renshaw rating of Ring Energy (NYSEAMERICAN:REI) on 8/29/2016
DarioHealth stock logo
DRIO
DarioHealth
$0.55
-4.0%
8/22/2016Ram SelvarajuReiterated RatingBuy$12.00View details for Rodman & Renshaw rating of DarioHealth (NASDAQ:DRIO) on 8/22/2016
Oramed Pharmaceuticals stock logo
ORMP
Oramed Pharmaceuticals
$2.12
-1.4%
8/21/2016Ram SelvarajuReiterated RatingBuy$25.00View details for Rodman & Renshaw rating of Oramed Pharmaceuticals (NASDAQ:ORMP) on 8/21/2016
Abeona Therapeutics stock logo
ABEO
Abeona Therapeutics
$6.49
+1.9%
8/21/2016-Reiterated RatingBuy$425.00View details for Rodman & Renshaw rating of Abeona Therapeutics (NASDAQ:ABEO) on 8/21/2016
Sierra Metals stock logo
SMT
Sierra Metals
C$1.15
8/18/2016-Reiterated RatingBuyC$3.00View details for Rodman & Renshaw rating of Sierra Metals (TSE:SMT) on 8/18/2016
Energy Focus stock logo
EFOI
Energy Focus
$2.01
-3.4%
8/15/2016-Boost Price TargetBuy$280.00 -> $560.00View details for Rodman & Renshaw rating of Energy Focus (NASDAQ:EFOI) on 8/15/2016
Bausch Health Cos stock logo
BHC
Bausch Health Cos
$5.71
-3.1%
8/9/2016Ram SelvarajuLower Price TargetBuy$90.00 -> $81.00View details for Rodman & Renshaw rating of Bausch Health Cos (NYSE:BHC) on 8/9/2016
Abeona Therapeutics stock logo
ABEO
Abeona Therapeutics
$6.49
+1.9%
8/5/2016-Reiterated RatingBuy$425.00View details for Rodman & Renshaw rating of Abeona Therapeutics (NASDAQ:ABEO) on 8/5/2016
DURECT stock logo
DRRX
DURECT
$1.84
-1.9%
8/3/2016Ram SelvarajuReiterated RatingBuy$40.00View details for Rodman & Renshaw rating of DURECT (NASDAQ:DRRX) on 8/3/2016
Bausch Health Cos stock logo
BHC
Bausch Health Cos
$5.71
-3.1%
7/28/2016Ram SelvarajuReiterated RatingBuy$90.00View details for Rodman & Renshaw rating of Bausch Health Cos (NYSE:BHC) on 7/28/2016
Kura Oncology stock logo
KURA
Kura Oncology
$6.02
-0.5%
7/18/2016-Reiterated RatingBuyView details for Rodman & Renshaw rating of Kura Oncology (NASDAQ:KURA) on 7/18/2016
Ford Motor stock logo
F
Ford Motor
$10.80
-2.4%
7/18/2016-Initiated CoverageBuyView details for Rodman & Renshaw rating of Ford Motor (NYSE:F) on 7/18/2016
Orion Energy Systems stock logo
OESX
Orion Energy Systems
$0.59
-1.2%
7/18/2016-Initiated CoverageBuy$2.50View details for Rodman & Renshaw rating of Orion Energy Systems (NASDAQ:OESX) on 7/18/2016
Bausch Health Cos stock logo
BHC
Bausch Health Cos
$5.71
-3.1%
7/17/2016Ram SelvarajuReiterated RatingBuy$90.00View details for Rodman & Renshaw rating of Bausch Health Cos (NYSE:BHC) on 7/17/2016
Protalix BioTherapeutics stock logo
PLX
Protalix BioTherapeutics
$1.45
-0.7%
7/11/2016Ram SelvarajuReiterated RatingBuyView details for Rodman & Renshaw rating of Protalix BioTherapeutics (NYSE:PLX) on 7/11/2016
Bausch Health Cos stock logo
BHC
Bausch Health Cos
$5.71
-3.1%
7/6/2016Ram SelvarajuReiterated RatingBuy$90.00View details for Rodman & Renshaw rating of Bausch Health Cos (NYSE:BHC) on 7/6/2016
DURECT stock logo
DRRX
DURECT
$1.84
-1.9%
7/6/2016Ram SelvarajuReiterated RatingBuy$40.00View details for Rodman & Renshaw rating of DURECT (NASDAQ:DRRX) on 7/6/2016
Crescent Biopharma stock logo
CBIO
Crescent Biopharma
$12.00
-3.4%
6/30/2016-Initiated CoverageBuy$5,250.00View details for Rodman & Renshaw rating of Crescent Biopharma (NASDAQ:CBIO) on 6/30/2016
Inovio Pharmaceuticals stock logo
INO
Inovio Pharmaceuticals
$1.43
+0.7%
6/21/2016-Reiterated RatingBuy$2,448.00View details for Rodman & Renshaw rating of Inovio Pharmaceuticals (NASDAQ:INO) on 6/21/2016
Westport Fuel Systems stock logo
WPRT
Westport Fuel Systems
$3.66
-1.6%
6/20/2016-Initiated CoverageBuy$50.00View details for Rodman & Renshaw rating of Westport Fuel Systems (NASDAQ:WPRT) on 6/20/2016
VolitionRX stock logo
VNRX
VolitionRX
$0.64
-0.2%
6/16/2016Ram SelvarajuReiterated RatingBuyView details for Rodman & Renshaw rating of VolitionRX (NYSEAMERICAN:VNRX) on 6/16/2016
Kura Oncology stock logo
KURA
Kura Oncology
$6.02
-0.5%
5/24/2016-Reiterated RatingBuyView details for Rodman & Renshaw rating of Kura Oncology (NASDAQ:KURA) on 5/24/2016
DarioHealth stock logo
DRIO
DarioHealth
$0.55
-4.0%
5/24/2016Ram SelvarajuReiterated RatingBuy$12.00View details for Rodman & Renshaw rating of DarioHealth (NASDAQ:DRIO) on 5/24/2016
Abeona Therapeutics stock logo
ABEO
Abeona Therapeutics
$6.49
+1.9%
5/18/2016-Reiterated RatingBuy$425.00View details for Rodman & Renshaw rating of Abeona Therapeutics (NASDAQ:ABEO) on 5/18/2016
VolitionRX stock logo
VNRX
VolitionRX
$0.64
-0.2%
5/16/2016Ram SelvarajuReiterated RatingBuyView details for Rodman & Renshaw rating of VolitionRX (NYSEAMERICAN:VNRX) on 5/16/2016
DURECT stock logo
DRRX
DURECT
$1.84
-1.9%
5/13/2016Ram SelvarajuReiterated RatingBuy$40.00View details for Rodman & Renshaw rating of DURECT (NASDAQ:DRRX) on 5/13/2016
Oramed Pharmaceuticals stock logo
ORMP
Oramed Pharmaceuticals
$2.12
-1.4%
5/13/2016Ram SelvarajuReiterated RatingBuy$25.00View details for Rodman & Renshaw rating of Oramed Pharmaceuticals (NASDAQ:ORMP) on 5/13/2016
Microbot Medical stock logo
MBOT
Microbot Medical
$2.55
+0.8%
5/10/2016Ram SelvarajuReiterated RatingBuyView details for Rodman & Renshaw rating of Microbot Medical (NASDAQ:MBOT) on 5/10/2016
DarioHealth stock logo
DRIO
DarioHealth
$0.55
-4.0%
5/9/2016-Initiated CoverageBuy$12.00View details for Rodman & Renshaw rating of DarioHealth (NASDAQ:DRIO) on 5/9/2016
Bausch Health Cos stock logo
BHC
Bausch Health Cos
$5.71
-3.1%
5/3/2016Ram SelvarajuLower Price TargetBuy$105.00 -> $102.00View details for Rodman & Renshaw rating of Bausch Health Cos (NYSE:BHC) on 5/3/2016
Bausch Health Cos stock logo
BHC
Bausch Health Cos
$5.71
-3.1%
4/26/2016Ram SelvarajuReiterated RatingBuy$105.00View details for Rodman & Renshaw rating of Bausch Health Cos (NYSE:BHC) on 4/26/2016
DURECT stock logo
DRRX
DURECT
$1.84
-1.9%
4/25/2016-Initiated CoverageBuy$40.00View details for Rodman & Renshaw rating of DURECT (NASDAQ:DRRX) on 4/25/2016
VolitionRX stock logo
VNRX
VolitionRX
$0.64
-0.2%
4/21/2016Ram SelvarajuReiterated RatingBuyView details for Rodman & Renshaw rating of VolitionRX (NYSEAMERICAN:VNRX) on 4/21/2016
Abeona Therapeutics stock logo
ABEO
Abeona Therapeutics
$6.49
+1.9%
4/20/2016-Reiterated RatingBuy$425.00View details for Rodman & Renshaw rating of Abeona Therapeutics (NASDAQ:ABEO) on 4/20/2016
Microbot Medical stock logo
MBOT
Microbot Medical
$2.55
+0.8%
4/20/2016-Initiated CoverageBuy$18.00View details for Rodman & Renshaw rating of Microbot Medical (NASDAQ:MBOT) on 4/20/2016
First Majestic Silver stock logo
AG
First Majestic Silver
$7.84
-1.4%
4/15/2016-Boost Price TargetBuy$6.00 -> $8.75View details for Rodman & Renshaw rating of First Majestic Silver (NYSE:AG) on 4/15/2016
Semler Scientific stock logo
SMLR
Semler Scientific
$34.46
-3.9%
4/15/2016-Initiated CoverageBuy$8.00View details for Rodman & Renshaw rating of Semler Scientific (NASDAQ:SMLR) on 4/15/2016
Trump’s national nightmare is here (Ad)

Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.

Watch the National Emergency broadcast here
Endeavour Silver stock logo
EXK
Endeavour Silver
$4.97
-2.0%
4/12/2016-Boost Price TargetBuy$2.50 -> $3.40View details for Rodman & Renshaw rating of Endeavour Silver (NYSE:EXK) on 4/12/2016
Bausch Health Cos stock logo
BHC
Bausch Health Cos
$5.71
-3.1%
4/11/2016Ram SelvarajuLower Price TargetBuy$118.00 -> $105.00View details for Rodman & Renshaw rating of Bausch Health Cos (NYSE:BHC) on 4/11/2016
Inovio Pharmaceuticals stock logo
INO
Inovio Pharmaceuticals
$1.43
+0.7%
4/9/2016-Reiterated RatingBuyView details for Rodman & Renshaw rating of Inovio Pharmaceuticals (NASDAQ:INO) on 4/9/2016
VolitionRX stock logo
VNRX
VolitionRX
$0.64
-0.2%
4/9/2016Ram SelvarajuReiterated RatingBuyView details for Rodman & Renshaw rating of VolitionRX (NYSEAMERICAN:VNRX) on 4/9/2016
Kura Oncology stock logo
KURA
Kura Oncology
$6.02
-0.5%
4/4/2016-Initiated CoverageBuy$52,500.00View details for Rodman & Renshaw rating of Kura Oncology (NASDAQ:KURA) on 4/4/2016
Protalix BioTherapeutics stock logo
PLX
Protalix BioTherapeutics
$1.45
-0.7%
4/4/2016-Initiated CoverageBuy$35.00View details for Rodman & Renshaw rating of Protalix BioTherapeutics (NYSE:PLX) on 4/4/2016
Bausch Health Cos stock logo
BHC
Bausch Health Cos
$5.71
-3.1%
4/3/2016Ram SelvarajuReiterated RatingBuyView details for Rodman & Renshaw rating of Bausch Health Cos (NYSE:BHC) on 4/3/2016
American Superconductor stock logo
AMSC
American Superconductor
$53.75
-5.5%
4/1/2016Amit DayalReiterated RatingNeutralView details for Rodman & Renshaw rating of American Superconductor (NASDAQ:AMSC) on 4/1/2016
Bausch Health Cos stock logo
BHC
Bausch Health Cos
$5.71
-3.1%
3/28/2016Ram SelvarajuReiterated RatingBuy$118.00View details for Rodman & Renshaw rating of Bausch Health Cos (NYSE:BHC) on 3/28/2016
Bausch Health Cos stock logo
BHC
Bausch Health Cos
$5.71
-3.1%
3/22/2016Ram SelvarajuReiterated RatingBuyView details for Rodman & Renshaw rating of Bausch Health Cos (NYSE:BHC) on 3/22/2016
Nano Dimension stock logo
NNDM
Nano Dimension
$1.35
-3.6%
3/21/2016-Initiated CoverageBuy$700.00View details for Rodman & Renshaw rating of Nano Dimension (NASDAQ:NNDM) on 3/21/2016
Inovio Pharmaceuticals stock logo
INO
Inovio Pharmaceuticals
$1.43
+0.7%
3/20/2016-Reiterated RatingBuyView details for Rodman & Renshaw rating of Inovio Pharmaceuticals (NASDAQ:INO) on 3/20/2016
Energy Fuels stock logo
UUUU
Energy Fuels
$8.85
-2.6%
3/17/2016-Lower Price TargetBuy$6.90 -> $6.30View details for Rodman & Renshaw rating of Energy Fuels (NYSEAMERICAN:UUUU) on 3/17/2016
CorMedix stock logo
CRMD
CorMedix
$11.64
-0.3%
3/17/2016-Boost Price TargetBuy$32.50 -> $37.50View details for Rodman & Renshaw rating of CorMedix (NASDAQ:CRMD) on 3/17/2016
Bausch Health Cos stock logo
BHC
Bausch Health Cos
$5.71
-3.1%
3/16/2016Ram SelvarajuLower Price TargetBuy$150.00 -> $118.00View details for Rodman & Renshaw rating of Bausch Health Cos (NYSE:BHC) on 3/16/2016
McEwen stock logo
MUX
McEwen
$10.05
-1.1%
3/14/2016-Boost Price Target$13.00 -> $24.00View details for Rodman & Renshaw rating of McEwen (NYSE:MUX) on 3/14/2016
VolitionRX stock logo
VNRX
VolitionRX
$0.64
-0.2%
3/14/2016-Reiterated RatingBuy$12.00View details for Rodman & Renshaw rating of VolitionRX (NYSEAMERICAN:VNRX) on 3/14/2016
Inseego stock logo
INSG
Inseego
$6.40
-3.3%
3/7/2016-Lower Price TargetBuy$60.00 -> $30.00View details for Rodman & Renshaw rating of Inseego (NASDAQ:INSG) on 3/7/2016
PolyMet Mining stock logo
PLM
PolyMet Mining
$2.10
-0.5%
3/4/2016-Boost Price TargetBuy$2.00 -> $2.40View details for Rodman & Renshaw rating of PolyMet Mining (NYSEAMERICAN:PLM) on 3/4/2016
Bausch Health Cos stock logo
BHC
Bausch Health Cos
$5.71
-3.1%
3/2/2016Ram SelvarajuReiterated RatingBuyView details for Rodman & Renshaw rating of Bausch Health Cos (NYSE:BHC) on 3/2/2016
First Majestic Silver stock logo
AG
First Majestic Silver
$7.84
-1.4%
2/29/2016-Initiated CoverageBuy$6.00View details for Rodman & Renshaw rating of First Majestic Silver (NYSE:AG) on 2/29/2016
Endeavour Silver stock logo
EXK
Endeavour Silver
$4.97
-2.0%
2/29/2016-Initiated CoverageBuy$2.50View details for Rodman & Renshaw rating of Endeavour Silver (NYSE:EXK) on 2/29/2016
Bausch Health Cos stock logo
BHC
Bausch Health Cos
$5.71
-3.1%
2/23/2016Ram SelvarajuReiterated RatingBuy$150.00View details for Rodman & Renshaw rating of Bausch Health Cos (NYSE:BHC) on 2/23/2016
Radcom stock logo
RDCM
Radcom
$13.09
-3.5%
2/18/2016-Boost Price TargetBuy$12.00 -> $16.00View details for Rodman & Renshaw rating of Radcom (NASDAQ:RDCM) on 2/18/2016
Bausch Health Cos stock logo
BHC
Bausch Health Cos
$5.71
-3.1%
2/16/2016-Initiated CoverageBuy$150.00View details for Rodman & Renshaw rating of Bausch Health Cos (NYSE:BHC) on 2/16/2016
Trilogy Metals stock logo
TMQ
Trilogy Metals
$1.59
+1.3%
2/11/2016-Reiterated RatingBuy$1.40 -> $1.30View details for Rodman & Renshaw rating of Trilogy Metals (NYSEAMERICAN:TMQ) on 2/11/2016
Trilogy Metals stock logo
TMQ
Trilogy Metals
$1.59
+1.3%
2/10/2016-Lower Price TargetBuy$1.40 -> $1.30View details for Rodman & Renshaw rating of Trilogy Metals (NYSEAMERICAN:TMQ) on 2/10/2016
BioCryst Pharmaceuticals stock logo
BCRX
BioCryst Pharmaceuticals
$7.95
-2.3%
2/9/2016-Lower Price TargetBuy$24.00 -> $10.00View details for Rodman & Renshaw rating of BioCryst Pharmaceuticals (NASDAQ:BCRX) on 2/9/2016
VolitionRX stock logo
VNRX
VolitionRX
$0.64
-0.2%
2/1/2016-Initiated CoverageBuy$12.00View details for Rodman & Renshaw rating of VolitionRX (NYSEAMERICAN:VNRX) on 2/1/2016
Inovio Pharmaceuticals stock logo
INO
Inovio Pharmaceuticals
$1.43
+0.7%
1/29/2016-Reiterated RatingBuyView details for Rodman & Renshaw rating of Inovio Pharmaceuticals (NASDAQ:INO) on 1/29/2016
Ideal Power stock logo
IPWR
Ideal Power
$4.34
-9.6%
1/26/2016-Initiated CoverageBuy$12.00View details for Rodman & Renshaw rating of Ideal Power (NASDAQ:IPWR) on 1/26/2016
American Superconductor stock logo
AMSC
American Superconductor
$53.75
-5.5%
1/13/2016-Initiated CoverageBuy$10.00View details for Rodman & Renshaw rating of American Superconductor (NASDAQ:AMSC) on 1/13/2016
Oramed Pharmaceuticals stock logo
ORMP
Oramed Pharmaceuticals
$2.12
-1.4%
1/10/2016-Reiterated RatingBuy$25.00View details for Rodman & Renshaw rating of Oramed Pharmaceuticals (NASDAQ:ORMP) on 1/10/2016
GoGold Resources stock logo
GGD
GoGold Resources
C$2.04
+1.0%
12/21/2015-Boost Price TargetC$2.70 -> C$2.90View details for Rodman & Renshaw rating of GoGold Resources (TSE:GGD) on 12/21/2015
Microvision stock logo
MVIS
Microvision
$1.09
-1.8%
12/17/2015-Initiated CoverageBuy$3.50View details for Rodman & Renshaw rating of Microvision (NASDAQ:MVIS) on 12/17/2015
CorMedix stock logo
CRMD
CorMedix
$11.64
-0.3%
12/16/2015-Initiated CoverageBuyView details for Rodman & Renshaw rating of CorMedix (NASDAQ:CRMD) on 12/16/2015
Vuzix stock logo
VUZI
Vuzix
$1.94
-3.5%
12/10/2015-Initiated CoverageBuy$10.00View details for Rodman & Renshaw rating of Vuzix (NASDAQ:VUZI) on 12/10/2015
CorMedix stock logo
CRMD
CorMedix
$11.64
-0.3%
11/12/2015-Initiated CoverageBuy$32.50View details for Rodman & Renshaw rating of CorMedix (NASDAQ:CRMD) on 11/12/2015
Ballard Power Systems stock logo
BLDP
Ballard Power Systems
$1.79
-2.2%
10/5/2015-Reiterated RatingBuyView details for Rodman & Renshaw rating of Ballard Power Systems (NASDAQ:BLDP) on 10/5/2015
Oramed Pharmaceuticals stock logo
ORMP
Oramed Pharmaceuticals
$2.12
-1.4%
10/1/2015-Initiated CoverageBuy$24.00View details for Rodman & Renshaw rating of Oramed Pharmaceuticals (NASDAQ:ORMP) on 10/1/2015
Ballard Power Systems stock logo
BLDP
Ballard Power Systems
$1.79
-2.2%
8/20/2015-Initiated CoverageBuy$2.50View details for Rodman & Renshaw rating of Ballard Power Systems (NASDAQ:BLDP) on 8/20/2015
Gevo stock logo
GEVO
Gevo
$1.22
-6.2%
8/19/2015-Initiated CoverageBuy$100.00View details for Rodman & Renshaw rating of Gevo (NASDAQ:GEVO) on 8/19/2015
Energy Focus stock logo
EFOI
Energy Focus
$2.01
-3.4%
8/7/2015-Initiated CoverageBuy$630.00View details for Rodman & Renshaw rating of Energy Focus (NASDAQ:EFOI) on 8/7/2015
Ballard Power Systems stock logo
BLDP
Ballard Power Systems
$1.79
-2.2%
7/14/2015-Initiated CoverageBuyView details for Rodman & Renshaw rating of Ballard Power Systems (NASDAQ:BLDP) on 7/14/2015
Energy Focus stock logo
EFOI
Energy Focus
$2.01
-3.4%
6/25/2015-Initiated CoverageBuyView details for Rodman & Renshaw rating of Energy Focus (NASDAQ:EFOI) on 6/25/2015
Catalyst Pharmaceuticals stock logo
CPRX
Catalyst Pharmaceuticals
$21.12
-1.0%
8/27/2012-UpgradeMarket Perform -> Outperform$3.70View details for Rodman & Renshaw rating of Catalyst Pharmaceuticals (NASDAQ:CPRX) on 8/27/2012
Cytokinetics stock logo
CYTK
Cytokinetics
$36.69
-2.5%
7/31/2012-Reiterated RatingOutperform$2.00View details for Rodman & Renshaw rating of Cytokinetics (NASDAQ:CYTK) on 7/31/2012
Alnylam Pharmaceuticals stock logo
ALNY
Alnylam Pharmaceuticals
$401.80
+2.4%
7/31/2012-Reiterated RatingOutperform$22.00View details for Rodman & Renshaw rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 7/31/2012
Bristol Myers Squibb stock logo
BMY
Bristol Myers Squibb
$44.25
+2.2%
7/27/2012-Boost Price TargetOutperform$38.00 -> $39.50View details for Rodman & Renshaw rating of Bristol Myers Squibb (NYSE:BMY) on 7/27/2012
Amgen stock logo
AMGN
Amgen
$296.88
+0.6%
7/23/2012-Boost Price TargetOutperform$73.00 -> $89.00View details for Rodman & Renshaw rating of Amgen (NASDAQ:AMGN) on 7/23/2012
Trump’s national nightmare is here (Ad)

Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.

Watch the National Emergency broadcast here
Alnylam Pharmaceuticals stock logo
ALNY
Alnylam Pharmaceuticals
$401.80
+2.4%
7/16/2012-Reiterated RatingOutperformView details for Rodman & Renshaw rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 7/16/2012
Allegiant Travel stock logo
ALGT
Allegiant Travel
$48.12
-6.8%
7/13/2012-Boost Price TargetOutperform$72.00 -> $79.00View details for Rodman & Renshaw rating of Allegiant Travel (NASDAQ:ALGT) on 7/13/2012
Bristol Myers Squibb stock logo
BMY
Bristol Myers Squibb
$44.25
+2.2%
7/5/2012-Reiterated RatingMarket Perform$38.00View details for Rodman & Renshaw rating of Bristol Myers Squibb (NYSE:BMY) on 7/5/2012
Assembly Biosciences stock logo
ASMB
Assembly Biosciences
$18.40
+2.7%
6/26/2012-Lower Price Target$132.00View details for Rodman & Renshaw rating of Assembly Biosciences (NASDAQ:ASMB) on 6/26/2012
RPMT
Virtual Piggy
$0.45
6/25/2012-Initiated CoverageOutperform$5.00View details for Rodman & Renshaw rating of Virtual Piggy (OTCMKTS:RPMT) on 6/25/2012
Amgen stock logo
AMGN
Amgen
$296.88
+0.6%
6/21/2012-Boost Price TargetOutperform$57.00 -> $73.00View details for Rodman & Renshaw rating of Amgen (NASDAQ:AMGN) on 6/21/2012
MediciNova stock logo
MNOV
MediciNova
$1.43
+7.9%
6/19/2012-Reiterated RatingOutperformView details for Rodman & Renshaw rating of MediciNova (NASDAQ:MNOV) on 6/19/2012
Ducommun stock logo
DCO
Ducommun
$89.49
-1.6%
5/24/2012-Initiated CoverageMarket PerformView details for Rodman & Renshaw rating of Ducommun (NYSE:DCO) on 5/24/2012
Powell Industries stock logo
POWL
Powell Industries
$227.66
-4.0%
5/10/2012-UpgradeMarket Perform -> Outperform$43.00View details for Rodman & Renshaw rating of Powell Industries (NASDAQ:POWL) on 5/10/2012
Enpro stock logo
NPO
Enpro
$209.79
-1.2%
5/4/2012-Boost Price TargetOutperform$47.00 -> $50.00View details for Rodman & Renshaw rating of Enpro (NYSE:NPO) on 5/4/2012
Rockwell Medical stock logo
RMTI
Rockwell Medical
$0.96
+2.8%
4/24/2012-Initiated CoverageOutperform$176.00View details for Rodman & Renshaw rating of Rockwell Medical (NASDAQ:RMTI) on 4/24/2012
Stryker stock logo
SYK
Stryker
$378.62
-3.6%
4/20/2012-DowngradeOutperform -> Market PerformView details for Rodman & Renshaw rating of Stryker (NYSE:SYK) on 4/20/2012
Insulet stock logo
PODD
Insulet
$284.91
-1.2%
4/18/2012-UpgradeMarket Perform -> OutperformView details for Rodman & Renshaw rating of Insulet (NASDAQ:PODD) on 4/18/2012
TriMas stock logo
TRS
TriMas
$34.92
-2.3%
3/15/2012-Initiated CoverageOutperform$32.00View details for Rodman & Renshaw rating of TriMas (NASDAQ:TRS) on 3/15/2012
Omeros stock logo
OMER
Omeros
$3.61
-6.7%
3/13/2012-Boost Price TargetOutperform$13.00 -> $16.00View details for Rodman & Renshaw rating of Omeros (NASDAQ:OMER) on 3/13/2012
Amgen stock logo
AMGN
Amgen
$296.88
+0.6%
3/7/2012-Reiterated RatingOutperform$57.00View details for Rodman & Renshaw rating of Amgen (NASDAQ:AMGN) on 3/7/2012
Verastem stock logo
VSTM
Verastem
$6.08
-1.5%
3/7/2012-Initiated CoverageBuy -> Market PerformView details for Rodman & Renshaw rating of Verastem (NASDAQ:VSTM) on 3/7/2012
ANI Pharmaceuticals stock logo
ANIP
ANI Pharmaceuticals
$63.93
+0.9%
2/27/2012-Reiterated RatingMarket PerformView details for Rodman & Renshaw rating of ANI Pharmaceuticals (NASDAQ:ANIP) on 2/27/2012
Madrigal Pharmaceuticals stock logo
MDGL
Madrigal Pharmaceuticals
$302.17
-0.1%
2/22/2012-Reiterated RatingMarket Perform$8.00View details for Rodman & Renshaw rating of Madrigal Pharmaceuticals (NASDAQ:MDGL) on 2/22/2012
Magic Software Enterprises stock logo
MGIC
Magic Software Enterprises
$20.60
-0.5%
2/15/2012-Boost Price TargetOutperform$8.00 -> $10.00View details for Rodman & Renshaw rating of Magic Software Enterprises (NASDAQ:MGIC) on 2/15/2012
Alnylam Pharmaceuticals stock logo
ALNY
Alnylam Pharmaceuticals
$401.80
+2.4%
2/6/2012-Boost Price TargetOutperform$19.00View details for Rodman & Renshaw rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 2/6/2012
Delta Air Lines stock logo
DAL
Delta Air Lines
$51.15
-3.9%
2/6/2012-Reiterated RatingOutperform$14.00View details for Rodman & Renshaw rating of Delta Air Lines (NYSE:DAL) on 2/6/2012
Allegiant Travel stock logo
ALGT
Allegiant Travel
$48.12
-6.8%
2/2/2012-Boost Price Target$62.00View details for Rodman & Renshaw rating of Allegiant Travel (NASDAQ:ALGT) on 2/2/2012
Powell Industries stock logo
POWL
Powell Industries
$227.66
-4.0%
1/26/2012-Initiated CoverageMarket PerformView details for Rodman & Renshaw rating of Powell Industries (NASDAQ:POWL) on 1/26/2012
Silicom stock logo
SILC
Silicom
$17.63
+6.8%
1/24/2012-Boost Price TargetOutperform$20.00 -> $25.00View details for Rodman & Renshaw rating of Silicom (NASDAQ:SILC) on 1/24/2012
Bristol Myers Squibb stock logo
BMY
Bristol Myers Squibb
$44.25
+2.2%
1/23/2012-Reiterated RatingOutperform$51.00View details for Rodman & Renshaw rating of Bristol Myers Squibb (NYSE:BMY) on 1/23/2012
Southwest Airlines stock logo
LUV
Southwest Airlines
$29.81
-3.6%
1/20/2012-Reiterated RatingOutperform$12.00View details for Rodman & Renshaw rating of Southwest Airlines (NYSE:LUV) on 1/20/2012
Amgen stock logo
AMGN
Amgen
$296.88
+0.6%
1/17/2012-Reiterated RatingOutperform$57.00View details for Rodman & Renshaw rating of Amgen (NASDAQ:AMGN) on 1/17/2012
Madrigal Pharmaceuticals stock logo
MDGL
Madrigal Pharmaceuticals
$302.17
-0.1%
1/5/2012-Initiated CoverageOutperform$8.00View details for Rodman & Renshaw rating of Madrigal Pharmaceuticals (NASDAQ:MDGL) on 1/5/2012
Alnylam Pharmaceuticals stock logo
ALNY
Alnylam Pharmaceuticals
$401.80
+2.4%
1/4/2012-Reiterated RatingOutperform$12.00View details for Rodman & Renshaw rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 1/4/2012
Woodward stock logo
WWD
Woodward
$259.29
+0.9%
1/4/2012-Initiated CoverageOutperform$52.00View details for Rodman & Renshaw rating of Woodward (NASDAQ:WWD) on 1/4/2012
Amgen stock logo
AMGN
Amgen
$296.88
+0.6%
12/23/2011-Reiterated RatingOutperform$57.00View details for Rodman & Renshaw rating of Amgen (NASDAQ:AMGN) on 12/23/2011
ANI Pharmaceuticals stock logo
ANIP
ANI Pharmaceuticals
$63.93
+0.9%
12/15/2011-DowngradeOutperform -> Market PerformView details for Rodman & Renshaw rating of ANI Pharmaceuticals (NASDAQ:ANIP) on 12/15/2011
Intel stock logo
INTC
Intel
$19.31
-2.5%
12/13/2011-Reiterated RatingOutperform$27.00View details for Rodman & Renshaw rating of Intel (NASDAQ:INTC) on 12/13/2011
Bristol Myers Squibb stock logo
BMY
Bristol Myers Squibb
$44.25
+2.2%
12/13/2011-Lower Price Target$51.00View details for Rodman & Renshaw rating of Bristol Myers Squibb (NYSE:BMY) on 12/13/2011
Alnylam Pharmaceuticals stock logo
ALNY
Alnylam Pharmaceuticals
$401.80
+2.4%
12/12/2011-Reiterated RatingOutperform$12.00View details for Rodman & Renshaw rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 12/12/2011
Bristol Myers Squibb stock logo
BMY
Bristol Myers Squibb
$44.25
+2.2%
12/12/2011-Reiterated RatingOutperform$52.50View details for Rodman & Renshaw rating of Bristol Myers Squibb (NYSE:BMY) on 12/12/2011
Omeros stock logo
OMER
Omeros
$3.61
-6.7%
12/5/2011-UpgradeMarket Perform -> Outperform$13.00View details for Rodman & Renshaw rating of Omeros (NASDAQ:OMER) on 12/5/2011
Rogers stock logo
ROG
Rogers
$67.36
+2.7%
12/2/2011-Initiated CoverageOutperform$55.00View details for Rodman & Renshaw rating of Rogers (NYSE:ROG) on 12/2/2011
Alnylam Pharmaceuticals stock logo
ALNY
Alnylam Pharmaceuticals
$401.80
+2.4%
12/1/2011-Reiterated RatingOutperformView details for Rodman & Renshaw rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 12/1/2011
Amgen stock logo
AMGN
Amgen
$296.88
+0.6%
12/1/2011-Initiated CoverageOutperform$62.00View details for Rodman & Renshaw rating of Amgen (NASDAQ:AMGN) on 12/1/2011
Curis stock logo
CRIS
Curis
$1.63
-1.8%
11/30/2011-Reiterated RatingOutperform$600.00View details for Rodman & Renshaw rating of Curis (NASDAQ:CRIS) on 11/30/2011
Edwards Lifesciences stock logo
EW
Edwards Lifesciences
$79.30
0.0%
11/29/2011-Reiterated RatingMarket PerformView details for Rodman & Renshaw rating of Edwards Lifesciences (NYSE:EW) on 11/29/2011
Apple stock logo
AAPL
Apple
$202.38
-2.5%
11/29/2011-Reiterated RatingOutperform$16.07View details for Rodman & Renshaw rating of Apple (NASDAQ:AAPL) on 11/29/2011
Southwest Airlines stock logo
LUV
Southwest Airlines
$29.81
-3.6%
11/21/2011-Reiterated RatingOutperform$12.00View details for Rodman & Renshaw rating of Southwest Airlines (NYSE:LUV) on 11/21/2011
Dell Technologies stock logo
DELL
Dell Technologies
$127.29
-4.1%
11/15/2011-Reiterated RatingOutperform$18.00View details for Rodman & Renshaw rating of Dell Technologies (NYSE:DELL) on 11/15/2011
Edwards Lifesciences stock logo
EW
Edwards Lifesciences
$79.30
0.0%
11/11/2011-Reiterated RatingMarket PerformView details for Rodman & Renshaw rating of Edwards Lifesciences (NYSE:EW) on 11/11/2011
Adient stock logo
ADNT
Adient
$21.40
-0.2%
11/11/2011-Initiated CoverageMarket PerformView details for Rodman & Renshaw rating of Adient (NYSE:ADNT) on 11/11/2011
Alnylam Pharmaceuticals stock logo
ALNY
Alnylam Pharmaceuticals
$401.80
+2.4%
11/10/2011-Reiterated RatingOutperformView details for Rodman & Renshaw rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 11/10/2011
Intel stock logo
INTC
Intel
$19.31
-2.5%
11/10/2011-Reiterated RatingOutperformView details for Rodman & Renshaw rating of Intel (NASDAQ:INTC) on 11/10/2011
Curis stock logo
CRIS
Curis
$1.63
-1.8%
11/10/2011-Reiterated RatingOutperform$600.00View details for Rodman & Renshaw rating of Curis (NASDAQ:CRIS) on 11/10/2011
Apple stock logo
AAPL
Apple
$202.38
-2.5%
11/9/2011-Reiterated RatingOutperformView details for Rodman & Renshaw rating of Apple (NASDAQ:AAPL) on 11/9/2011
Geron stock logo
GERN
Geron
$1.17
+1.7%
11/9/2011-Lower Price Target$4.00View details for Rodman & Renshaw rating of Geron (NASDAQ:GERN) on 11/9/2011
Bristol Myers Squibb stock logo
BMY
Bristol Myers Squibb
$44.25
+2.2%
11/9/2011-Reiterated RatingOutperform$52.50View details for Rodman & Renshaw rating of Bristol Myers Squibb (NYSE:BMY) on 11/9/2011
U.S. Energy stock logo
USEG
U.S. Energy
$1.18
-1.7%
11/8/2011-Reiterated RatingOutperform$47.50View details for Rodman & Renshaw rating of U.S. Energy (NASDAQ:USEG) on 11/8/2011
Energy Recovery stock logo
ERII
Energy Recovery
$12.79
-4.9%
11/4/2011-Reiterated RatingMarket PerformView details for Rodman & Renshaw rating of Energy Recovery (NASDAQ:ERII) on 11/4/2011
AudioCodes stock logo
AUDC
AudioCodes
$9.68
-3.4%
11/1/2011-Reiterated RatingOutperformView details for Rodman & Renshaw rating of AudioCodes (NASDAQ:AUDC) on 11/1/2011
Cytokinetics stock logo
CYTK
Cytokinetics
$36.69
-2.5%
11/1/2011-Reiterated RatingOutperform$4.00View details for Rodman & Renshaw rating of Cytokinetics (NASDAQ:CYTK) on 11/1/2011
Alnylam Pharmaceuticals stock logo
ALNY
Alnylam Pharmaceuticals
$401.80
+2.4%
11/1/2011-Reiterated RatingOutperform$12.00View details for Rodman & Renshaw rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 11/1/2011
Bristol Myers Squibb stock logo
BMY
Bristol Myers Squibb
$44.25
+2.2%
10/28/2011-Reiterated RatingOutperform$52.50View details for Rodman & Renshaw rating of Bristol Myers Squibb (NYSE:BMY) on 10/28/2011

MarketBeat Community Rating for Rodman & Renshaw

Community Ranking:  2.6 out of 5 (
2.6 of 5 stars)
Outperform Votes:  49,937 (Vote Outperform)
Underperform Votes:  47,192 (Vote Underperform)
Total Votes:  97,129
MarketBeat's community ratings are surveys of what our community members think about Rodman & Renshaw and other research firms. Vote "Outperform" if you believe Rodman & Renshaw's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Rodman & Renshaw's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.